NCT00677105View on ClinicalTrials.gov

A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

LymphomaNeoplasms

Interventions

DRUG

JNJ-26481585

Trial Locations (6)

Unknown

Glasgow

Leeds

London

Manchester

Newcastel Upon Tyne

Sutton

All Listed Sponsors

collaborator

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00677105 - A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. | Biotech Hunter | Biotech Hunter